Motilal Oswal's research report on Grasim
Grasim reported an EBITDA of INR6.7b (vs. est. INR5.2b) and OPM of 10.8% (vs. est. 8.2%) in 1QFY24. The beat was driven by VSF segment that posted an EBITDA/kg of INR19.9 (vs. est. INR13.8/kg) and Chemical segment that clocked an OPM of 16.7% (vs. est. 13.5%). Profit was at INR3.6b (vs. est. INR1.6b). Management believes that margins in both the key business segments, VSF and Chemical, have almost bottomed out. Lower input costs aided profitability improvement for the VSF segment and higher sales of VAPs. Further, increased chlorine integration supported sequential margin improvement in the Chemical segment. Commissioning of Lubrizol plant as well as increase in VAP capacities will help improve chlorine integration to 72% from 61% in Jun’23 (60% in FY23).
Outlook
We largely maintain our EBITDA estimates for FY24/FY25. Margin in the VSF segment witnessed a strong recovery and we expect EBITDA/kg to be at INR13/INR18 in FY24/25. Reiterate BUY with a TP of INR2,100 (Exhibit 9).
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.